Back to Results
First PageMeta Content
Acute myeloid leukemia / Cell signaling / CD135 / Leukemia / Quizartinib / Lintuzumab / Lestaurtinib / Oncology / Acute leukemia / Myeloid leukemia


    AMBIT BIOSCIENCES INITIATES FIRST PHASE 2 CLINICAL TRIAL OF AC220 IN ACUTE MYELOID LEUKEMIA    Potential to Support U.S. Regulatory Filing   
Add to Reading List

Document Date: 2011-08-15 11:58:25

Open Document

File Size: 129,87 KB

Share Result on Facebook
UPDATE